# Development and validation of prediction models for diabetic retinopathy in type 2 diabetes patients

**Authors:** Shadi Naderyan Feˈli, Mohammad Hassan Emamian, Mehdi Yaseri, Hamid Riazi-Esfahani, Hassan Hashemi, Akbar Fotouhi, Kamran Yazdani

PMC · DOI: 10.1371/journal.pone.0325814 · PLOS One · 2025-07-10

## TL;DR

This study developed and validated three models to predict the 5- and 10-year risk of diabetic retinopathy in type 2 diabetes patients using common clinical predictors.

## Contribution

The novel contribution is the creation and validation of three prediction models specifically for diabetic retinopathy risk in Iranian type 2 diabetes patients.

## Key findings

- Model-1 (5-year risk) achieved good discrimination with a c-statistic of 0.773 using MBP, BG, and diabetes duration.
- Model-2 (10-year risk) showed moderate discrimination with a c-statistic of 0.687 using diabetes duration, MBP, and BG.
- Model-3 (5-year risk) demonstrated good discrimination with a c-statistic of 0.735 using additional metabolic markers like HbA1c and lipid levels.

## Abstract

Prediction models enable healthcare providers to perform early risk stratification. This study aimed to develop and internally validate prediction models for 5- and 10-year risks of developing diabetic retinopathy (DR) in the Iranian individuals with type 2 diabetes.

This study utilized data from individuals with diabetes involved in the Shahroud Eye Cohort Study (ShECS), a prospective cohort study in Iran. The initial phase of ShECS began in 2009, with the second and third follow-up phases occurring in 2014 and 2019, respectively. Logistic regression developed prediction models, with bootstrap validation assessing internal validity. Model performance was evaluated using the discrimination and calibration.

A total of 637 individuals with diabetes (35.0% men, mean (SD) of age: 53.0 (6.3 years)) were diagnosed. The five-year cumulative incidence of DR was 25.3% (95%CI: 21.8, 29.0%), and 17.0% (95%CI: 13.3, 21.0%) based on the second and third phases, respectively, while 10-year cumulative incidence was 40.0% (95%CI: 35.8, 44.0%). Incorporating various predictors, six models were developed with three recommended prediction models. Using mean blood pressure (MBP), non-fasting blood glucose (BG), and diabetes duration, Model-1 predicts 5-year risk indicating good calibration and discrimination with a c-statistic of 0.773 after bootstrap validation. The optimal statistical threshold was a predicted probability of 0.24. Model-2 predicts a 10-year risk incorporating diabetes duration, MBP, and BG, with a good calibration and a c-statistic of 0.687 after bootstrap validation showing moderate discrimination. The optimal statistical threshold was a predicted probability of 0.32. Model-3 predicts the 5-year risk using diabetes duration, MBP, glycated hemoglobin, high-density lipoprotein, triglycerides, and fasting blood glucose, showing good calibration and a c-statistic of 0.735 after bootstrap validation, indicating good discrimination. The optimal statistical threshold was a predicted probability of 0.20.

Three prediction models with satisfactory performance were obtained using readily available predictors.

## Linked entities

- **Diseases:** diabetic retinopathy (MONDO:0005266), type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** DR (MESH:D003930), type 2 diabetes (MESH:D003924), diabetes (MESH:D003920)
- **Chemicals:** glucose (MESH:D005947), triglycerides (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12244548/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12244548/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12244548/full.md

---
Source: https://tomesphere.com/paper/PMC12244548